中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Polymorph transformation of solid drugs

文献类型:期刊论文

作者Zhang Qi; Mei Xuefeng
刊名Acta Pharmaceutica Sinica
出版日期2015
卷号50期号:5页码:521-527
关键词drug stability polymorphism transformation
ISSN号0513-4870
其他题名固体药物的转晶现象
文献子类Review
英文摘要For the minimized phase transforming risk, the most stable polymorph is generally considered as the desirable solid form for pharmaceutical applications. However, occasionally, the stable form may have some shortcomings such as low solubility, dissolution rate and bioavailability, etc. In that case, the metastable form which is kinetically stable at room or lower temperature could be selected. Using metastable form may result in polymorph transformation in pharmaceutical manufacture and storage. Hence, the knowledge of the transformation between solid forms is essential to the development of the drug materials. In this paper, we will review the recent studies in the area of crystal conversion of polymorphs and hydrates, to illustrate some cases to introduce the types, conditions and mechanisms of the crystalline solid transformation.
资助项目国家自然科学基金资助项目[00000000]
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:5410791
源URL[http://119.78.100.183/handle/2S10ELR8/269284]  
专题药物质量控制与固体化学研究中心
药物安全性评价中心
通讯作者Mei Xuefeng
作者单位Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200203, China.
推荐引用方式
GB/T 7714
Zhang Qi,Mei Xuefeng. Polymorph transformation of solid drugs[J]. Acta Pharmaceutica Sinica,2015,50(5):521-527.
APA Zhang Qi,&Mei Xuefeng.(2015).Polymorph transformation of solid drugs.Acta Pharmaceutica Sinica,50(5),521-527.
MLA Zhang Qi,et al."Polymorph transformation of solid drugs".Acta Pharmaceutica Sinica 50.5(2015):521-527.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。